Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines.

ABSTRACT:

Importance

It is estimated that, from 2023 to 2025, lung cancer (LC) will be the second most frequent cancer in Brazil, but the country does not have an LC screening (LCS) policy.

Objective

To compare the number of individuals eligible for screening, 5-year preventable LC deaths, and years of life gained (YLG) if LC death is averted by LCS, considering 3 eligibility strategies by sociodemographic characteristics.

Design, setting, and participants

This comparative effectiveness research study assessed 3 LCS criteria by applying a modified version of the LC-Death Risk Assessment Tool (LCDRAT) and the LC-Risk Assessment Tool (LCRAT). Data are from the 2019 Brazilian National Household Survey. Participants included ever-smokers aged 50 to 80 years. Data analysis was perfo

SUBMITTER: Emmerick ICM 

PROVIDER: S-EPMC10714246 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature